ABO-102(Arbor Biotechnologies)

N/A

Report date: 2025/08/13 16:51:11

Base Information

Drug NameABO-102(Arbor Biotechnologies)
Drug Alias NameABO-102
ClassificationCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionTransthyretin modulators
TargetsTransthyretin
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArbor Biotechnologies Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLiver Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A